Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lepor

Showing results (421-430 of 457) with videos related to

Pageof 46
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2011
Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasionYirong Li, Martin Ligr, James P McCarron, et al.
European Urology|June 27, 2015
Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy OutcomesXiaosong Meng, Andrew B Rosenkrantz, Neil Mendhiratta, et al.
Pathology, Research and Practice|May 7, 2022
Comparison of the clinicopathologic features of prostate cancer in US and Chinese populationsLei Zhang, Xiaoyan Liu, Rong Xia, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2018
Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesisMao-Wen Weng, Hyun-Wook Lee, Sung-Hyun Park, et al.
Radiation Oncology (London, England)|March 4, 2024
High-volume prostate biopsy core involvement is not associated with an increased risk of cancer recurrence following 5-fraction stereotactic body radiation therapy monotherapyJonathan W Lischalk, Astrid Sanchez, Vianca F Santos, et al.
Urology|December 11, 2003
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancerYoshio Naya, Herbert A Fritsche, Carol D Cheli, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterWolfgang Horninger, Carol D Cheli, Richard J Babaian, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202Amin J Mirhadi, Qiang Zhang, Gerald E Hanks, et al.
The New England Journal of Medicine|March 25, 2026
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor EnlicitideAnn Marie Navar, Elina Mikhailova, Alberico L Catapano, et al.
Urology|October 18, 2002
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?Yoshio Naya, Thomas A Stamey, Carol D Cheli, et al.
Pageof 46

Showing results (421-430 of 457) with videos related to

Sort By:
Pageof 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2011
Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasionYirong Li, Martin Ligr, James P McCarron, et al.
European Urology|June 27, 2015
Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy OutcomesXiaosong Meng, Andrew B Rosenkrantz, Neil Mendhiratta, et al.
Pathology, Research and Practice|May 7, 2022
Comparison of the clinicopathologic features of prostate cancer in US and Chinese populationsLei Zhang, Xiaoyan Liu, Rong Xia, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2018
Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesisMao-Wen Weng, Hyun-Wook Lee, Sung-Hyun Park, et al.
Radiation Oncology (London, England)|March 4, 2024
High-volume prostate biopsy core involvement is not associated with an increased risk of cancer recurrence following 5-fraction stereotactic body radiation therapy monotherapyJonathan W Lischalk, Astrid Sanchez, Vianca F Santos, et al.
Urology|December 11, 2003
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancerYoshio Naya, Herbert A Fritsche, Carol D Cheli, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterWolfgang Horninger, Carol D Cheli, Richard J Babaian, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2017
Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202Amin J Mirhadi, Qiang Zhang, Gerald E Hanks, et al.
The New England Journal of Medicine|March 25, 2026
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor EnlicitideAnn Marie Navar, Elina Mikhailova, Alberico L Catapano, et al.
Urology|October 18, 2002
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?Yoshio Naya, Thomas A Stamey, Carol D Cheli, et al.
Pageof 46